Page 1 | Search Results | Journal of Experimental Medicine | Rockefeller University Press

Skip to Main Content

Skip Nav Destination

1-3 of 3

Sort by

Sort Order Select

Journal Articles

Frequent disruption of the RB pathway in indolent follicular lymphoma suggests a new combination therapy

Elisa Oricchio, Giovanni Ciriello, Man Jiang, Michael H. Boice, Jonathan H. Schatz, Adriana Heguy, Agnes Viale, Elisa de Stanchina, Julie Teruya-Feldstein, Alyssa Bouska, Tim McKeithan, Chris Sander, Wayne Tam, Venkatraman E. Seshan, Wing-Chung Chan, R.S.K. Chaganti, Hans-Guido Wendel

J Exp Med (2014) 211 (7): 1379–1391.

https://doi.org/10.1084/jem.20132120

Published: 09 June 2014

View article titled, Frequent disruption of the RB pathway in indolent follicular lymphoma suggests a new combination therapy

Includes: Supplementary data

Journal Articles

Targeting cap-dependent translation blocks converging survival signals by AKT and PIM kinases in lymphoma

Jonathan H. Schatz, Elisa Oricchio, Andrew L. Wolfe, Man Jiang, Irina Linkov, Jocelyn Maragulia, Weiji Shi, Zhigang Zhang, Vinagolu K. Rajasekhar, Nen C. Pagano, John A. Porco, Jr., Julie Teruya-Feldstein, Neal Rosen, Andrew D. Zelenetz, Jerry Pelletier, Hans-Guido Wendel

J Exp Med (2011) 208 (9): 1799–1807.

https://doi.org/10.1084/jem.20110846

Published: 22 August 2011

View article titled, Targeting cap-dependent translation blocks converging survival signals by AKT and PIM kinases in lymphoma

Includes: Supplementary data

Journal Articles

Vasostatin, a Calreticulin Fragment, Inhibits Angiogenesis and Suppresses Tumor Growth

Sandra E. Pike, Lei Yao, Karen D. Jones, Barry Cherney, Ettore Appella, Kazuyasu Sakaguchi, Hira Nakhasi, Julie Teruya-Feldstein, Peter Wirth, Ghanshyam Gupta, Giovanna Tosato

J Exp Med (1998) 188 (12): 2349–2356.

https://doi.org/10.1084/jem.188.12.2349

Published: 21 December 1998

View article titled, Vasostatin, a Calreticulin Fragment, Inhibits Angiogenesis and Suppresses Tumor Growth